Clinical trial

HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903

NCT04975698

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-10-25

PhasePHASE2

Study timeline

Study start (actual)2021-10-25Date precision: day

Registry last updated2026-06-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Associated Lymphomaunresolved

Interventions

HST-NEETsBIOLOGICAL

Bone Marrow TransplantBIOLOGICAL

Sponsors & collaborators

Catherine Bollardlead sponsor

National Heart, Lung, and Blood Institute (NHLBI)collaborator

Blood and Marrow Transplant Clinical Trials Networkcollaborator

National Cancer Institute (NCI)collaborator

National Marrow Donor Programcollaborator

Children's National Research Institutecollaborator

Mapped research locations

New YorkNew York, United States2 HoustonTexas, United States2 ChicagoIllinois, United States1 PhiladelphiaPennsylvania, United States1 BaltimoreMaryland, United States1 AtlantaGeorgia, United States1 TampaFlorida, United States1 Washington D.C.District of Columbia, United States1 DuarteCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04975698 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.